biote Corp. BTMD
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -57.31%
- 1 year
- -60.07%
- Open
- 1.17
- Prev close
- 1.17
- Mkt cap
- 37.63M
- Vol
- 62.19K
- Avg vol
- 204.43K
- EPS
- 0.14
- P/E
- 7.93
- Div yield
- 0.00%
More statistics
- Low
- 1.11
- High
- 1.20
- Forward P/E
- 9.98
- Beta
- 0.00
- Short ratio
- 3.73
- Inst. own
- 64.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 5.88
- 200-d avg
- 6.21
- 1y target
- 9.95
6M chart
Signals (28)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| RSI: Oversold | Aug 17, 2026 | 2 months ago |
| RSI: Oversold | Aug 12, 2026 | 2 months ago |
| RSI: Oversold | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 6 months ago |
Key statistics
- Market cap
- 305.42M
- Enterprise value
- 287.07M
- Trailing P/E
- 19.30
- Forward P/E
- 9.98
- PEG ratio
- 0.00
- Price / sales
- 1.58
- Price / book
- 0.00
- EPS (TTM)
- 0.30
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.72%
- Revenue (TTM)
- 193.06M
- Revenue growth
- 12.80%
- Free cash flow
- 37.61M
- Total cash
- 38.23M
- Total debt
- 122.31M
- Return on equity
- 0.00%
- Shares outstanding
- 31.11M
- Short % of float
- 3.21%
- 50-day average
- 5.88
- 200-day average
- 6.21
Analyst view
Consensus: strong buy
- Target (low)
- 8.00
- Target (mean)
- 9.95
- Target (high)
- 12.00
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate 0.17.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.09 | 0.33 | +0.24 | +266.67% |
| Aug 8, 2024 | Jun 1, 2024 | 0.09 | 0.14 | +0.05 | +55.56% |
| Aug 8, 2024 | Jun 1, 2024 | 0.09 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.05 | 0.23 | +0.18 | +360.00% |
| May 7, 2024 | Mar 1, 2024 | 0.05 | — | — | — |
| Mar 12, 2024 | Dec 1, 2023 | 0.08 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Craig-Hallum | init | — | Buy |
| Mar 13, 2024 | Roth MKM | reit | Buy | Buy |
| Feb 20, 2024 | B. Riley Securities | init | — | Buy |
| Feb 1, 2024 | Jefferies | init | — | Buy |
| Jan 18, 2024 | Truist Securities | main | Buy | Buy |
| Jan 18, 2024 | Roth MKM | main | Buy | Buy |
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- biote.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BTMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEER MARC D | Director | Sale | Jan 8, 2023 | 0 |
| CONE STEPHEN MARK | Director | Conversion of Exercise of derivative security | Jun 29, 2023 | 122,725 |
| CONLON MARY ELIZABETH | General Counsel | Sale | Jul 4, 2023 | 140,393 |
| HEYER ANDREW R | Director | Purchase | Jan 8, 2023 | 0 |
| JACOBY DANA LYNN | Director | Conversion of Exercise of derivative security | May 20, 2024 | 50,970 |
| KAMDAR SAMAR JAGAT | Chief Financial Officer | Purchase | Jan 8, 2023 | 13,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| 325 Capital Llc | 14.32% | 4,548,127 | 26.33M | Sep 29, 2024 |
| Bandera Partners LLC | 7.67% | 2,435,635 | 14.10M | Sep 29, 2024 |
| Blackrock Inc. | 5.44% | 1,725,875 | 9.99M | Sep 29, 2024 |
| Vanguard Group Inc | 4.47% | 1,417,793 | 8.21M | Sep 29, 2024 |
| Wasatch Advisors LP | 4.39% | 1,392,809 | 8.06M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.14% | 678,459 | 3.93M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.70% | 856,603 | 4.96M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.12% | 673,534 | 3.90M | Oct 30, 2024 |
| Wasatch Micro-Cap Value Fund | 1.93% | 613,010 | 3.55M | Sep 29, 2024 |
| RBB Fund Inc.- Boston Partners Small Cap Value Fd II | 1.56% | 493,862 | 2.86M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.08% | 342,071 | 1.98M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.85% | 270,540 | 1.57M | Aug 30, 2024 |